CORC

浏览/检索结果: 共4条,第1-4条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial 期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载:113/0  |  提交时间:2019/12/05
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2016, 卷号: 34, 期号: 13
作者:  Li, Jin;  Qin, Shukui;  Xu, Jianming;  Xiong, Jianping;  Wu, Changping
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/06
Type 2 Diabetes Mellitus in China: A Preventable Economic Burden 期刊论文
AMERICAN JOURNAL OF MANAGED CARE, 2009, 卷号: 15, 期号: 9
作者:  Wang, Weibing;  McGreevey, William P.;  Fu, Chaowei;  Zhan, Siyan;  Luan, Rongsheng
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/19
How Do Type 2 Diabetes Mellitus-Related Chronic Complications Impact Direct Medical Cost in Four Major Cities of Urban China? 期刊论文
VALUE IN HEALTH, 2009, 卷号: 12, 期号: 6
作者:  Wang, Weibing;  Fu, Chao Wei;  Pan, Chang Yu;  Chen, Weiqing;  Zhan, Siyan
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace